- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0007425

Amaresha Pharmaceuticals Private Limited
About Amaresha Pharmaceuticals Private Limited
Data last updated:
Amaresha Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24290TN2017PTC117523. Its GSTIN is 33AAPCA7948B1ZL (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramalingasrinivasan and Sivaramakrishnan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at New No:11 B – 2 'A' 7th Street Nandanam Extension Nandanam, Chennai, Tamil Nadu, India – 600035.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.64 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹24,742 (net margin 1.5%) and EBITDA of ₹25,495 (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹6.57 Lakh on record.
Amaresha Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0007425). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Amaresha Pharmaceuticals
Contact details
Amaresha Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNew No:11 B – 2 'A' 7th Street Nandanam Extension Nandanam, Chennai, Tamil Nadu, India – 600035
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Amaresha Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amaresha Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Amaresha Pharmaceuticals Private Limited, buy the company report.
Financials of Amaresha Pharmaceuticals Private Limited
FY 2025 filings availableAmaresha Pharmaceuticals Private Limited reported revenue of ₹16.64 Lakh (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 13% growth in the latest year. EBITDA fell 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹25,495 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24,742 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amaresha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amaresha Pharmaceuticals Private Limited
Amaresha Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramalingasrinivasan | Director | 12 Jul 2017 | 9 Years 4 Months | Current |
| Sivaramakrishnan | Director | 12 Jul 2017 | 9 Years 4 Months | Current |
Peer comparison
Amaresha Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emars Perk Allen Private Limited | ₹16.71 Lakh (FY 2024) | -82.0% | Kolkata, West Bengal, India | |||
| Ekasar Lifesciences Private Limited | ₹16.68 Lakh (FY 2023) | -38.0% | Chandigarh, India | |||
| Ritz Pharmaceutical and Foods Products Private Limited | ₹16.68 Lakh (FY 2025) | -41.0% | Uttar Prdesh, Uttar Pradesh, India | |||
| Amaresha Pharmaceuticals Private Limitedthis company | ₹16.64 Lakh (FY 2024) | ₹24,742 | 1.5% | 13.0% | Chennai, Tamil Nadu, India | |
| Rupison Pharmaceuticals Private Limited | ₹16.61 Lakh (FY 2025) | 24.0% | Agra, Uttar Pradesh, India |
To see the full peer comparison of Amaresha Pharmaceuticals Private Limited, buy the company report.
Auditor
Amaresha Pharmaceuticals Private Limited is audited by SUJA & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUJA & CO | FY 2021 | 004183S |
Shareholding
The shareholding of Amaresha Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Amaresha Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2023 | 100842663 | Indian Overseas Bank | ₹6.57 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Amaresha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amaresha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amaresha Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAPCA7948B1ZL | Tamil Nadu | Active | 06 Oct 2017 |
To see the full GST registrations and return filing status of Amaresha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amaresha Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ramalingasrinivasan was appointed as Director on 12 Jul 2017.
Frequently asked questions
Amaresha Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 July 2017 (9+ years old) and is registered under CIN U24290TN2017PTC117523.
Amaresha Pharmaceuticals has 2 current directors:
- Ramalingasrinivasan - Director
- Sivaramakrishnan - Director
The latest financial statements of Amaresha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Amaresha Pharmaceuticals is 33AAPCA7948B1ZL, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Amaresha Pharmaceuticals is U24290TN2017PTC117523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amaresha Pharmaceuticals was incorporated on 12 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Amaresha Pharmaceuticals by revenue are Emars Perk Allen Private Limited, Ekasar Lifesciences Private Limited, Ritz Pharmaceutical and Foods Products Private Limited, Rupison Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Ramalingasrinivasan was appointed as Director on 12 Jul 2017. Sivaramakrishnan was appointed as Director on 12 Jul 2017.
Yes, Amaresha Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0007425).
The registered office of Amaresha Pharmaceuticals is at New No:11 B – 2 A 7th Street Nandanam Extension Nandanam, Chennai, Tamil Nadu, India – 600035.
Amaresha Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

